China Just Approved A New Weight-Loss Drug, And American Utility Firms Are Powering Up On Infrastructure Spending
- Author
- Finimize
- Published
- Tue 01 Jul 2025
- Episode Link
- None
China just approved a local drugmaker’s weight-loss medicine, effectively ending Novo Nordisk and Eli Lilly’s two-horse race, while US utility firms are set to make record infrastructure investments – but Big Tech may still go entirely off-grid.
Today’s stories:
